No Data
Zhitong Finance HK Stock November Investment Strategy and Top 10 Gold Stocks
Following the adjustment in October, opportunities in November are likely to increase, as a decline serves as the best litmus test, helping us identify which assets have stood the test of scrutiny. Therefore, the strategy need not be overly complex; regardless of market volatility, simply put: focus on resilient asset classes.
HKG Market Moves | Changfeng Pharmaceuticals (02652) rose nearly 3% before noon as the company completed the first patient enrollment for its minimally invasive interventional device in the treatment of emphysema.
Changfeng Pharmaceuticals (02652) rose nearly 3% in the morning session. As of the time of writing, it was up 2.74%, trading at HKD 29.2, with a turnover of HKD 5.3645 million.
Hong Kong IPO Weekly | Energy drink giant Eastroc Beverage resubmits listing application; three new stocks double in value
①Functional beverage giant Eastroc Beverage has filed again. What are the highlights? ②All three newly listed stocks doubled in value. Why is the market so enthusiastic?
Hong Kong Stocks Close | Three Major Indices Post Weekly Declines; IPO Performance Draws Attention
① What are the reasons for the adjustment in gold stocks today? ② What caused the significant drop in CATL?
Hong Kong Stocks End Lower Amid AI Bubble Fear; CF PharmTech Debuts In Hong Kong
Hong Kong Stocks Close (10.08) | Hang Seng Index Down 0.48%, Gold Stocks Continue to Surge, New Stock Changfeng Pharmaceutical (02652) Ends Up 161%
Hong Kong's three major indices opened lower and quickly plummeted, with the Hang Seng Index once falling by more than 1.6%. The losses gradually narrowed throughout the day thereafter.